Key Highlights
- Michael Emery appointed as CFO of Delphinus Medical Technologies.
- Over 30 years of financial executive leadership experience.
- Previously CFO and COO at Tyber Medical.
- Specialized in strategic financial planning and high-performance team building.
Source: Business Wire
Notable Quotes
- “Michael’s strong resume of strategic planning, financial management, and building high-performance teams makes him the ideal leader to help us execute our financial plan here at Delphinus. We are in an exciting time for our organization, where the potential for growth and long-term goal achievement is paramount and requires a financial leader who can position us for success.” — Scott White, CEO at Delphinus Medical Technologies
- “It is an honor to join a company that is experiencing immense growth as it enters into commercial stage. The SoftVue system addresses a large gap in the U.S. healthcare system for women with dense breast tissue.” — Michael Emery, Chief Financial Officer (CFO) at Delphinus Medical Technologies
SoHC's Take
Delphinus Medical Technologies’ decision to appoint Michael Emery as their new CFO is a strategic move that underscores their commitment to financial excellence and growth. Emery’s extensive background in financial management, particularly in the healthcare and medical device sectors, positions him as a valuable asset for Delphinus. His previous successes in aligning companies for financial success and operational efficiency will be instrumental as Delphinus continues to expand its market presence with the innovative SoftVue system. This move is likely to strengthen Delphinus’s financial strategies and support their mission to improve breast cancer detection for women with dense breast tissue.
